Contrary to an increased emphasis on data privacy globally, within the healthcare industry governments are pushing for more data transparency. Additionally, the increasing costs and difficulty of drug discovery requires healthcare organizations and pharmaceutical companies to be able to quickly connect to professionals and thought leaders with specific credentials or research history. H1 addresses these needs by allowing life sciences companies, hospitals, and healthcare systems to locate the professionals they need.
H1 is the world’s largest healthcare database. It acts a bit like LinkedIn for healthcare professionals, and has already built a network of more than 9 million users. It has also built a corporate client base of 250 enterprises which is able to access its data which spans more than 250 million patients and over 10 billion health care claims.
The company graduated from Y Combinator's accelerator program in January 2020 and capped off a successful year by closing a Series B funding round that December. In 2021, H1 worked to further expand the company into Europe and Asia. Following a successful 2022 Series C round the company is focusing on building out its data network and hiring additional talent.
Freddie
Company Specialist at Welcome to the Jungle